Now is the time to educate elected representatives and other state and local leaders about these policies and the public support behind them
In a 2017 study of more than 1,500 young adults in the US, roughly one in five said they identified as social smokers
Blu Rechargeable E-Cig Starter Kit Rechargeable / Refillable Electronic Cigarette The blu Original Starter Kit: Leading the Electronic Cigarette Revolution blu Original, the first and only electronic cigarette with the one-of-a-kind blu pack that started the ecig revolution
A new study out of Yale University says thirdhand smoke the tobacco contaminants that adhere to walls, bedding, carpet and other surfaces until a room smells like an ashtray can actually cling to a smokers body and clothes as well
Nina Kim, MD, MSc Associate Editor Professor of Medicine Division of Allergy & Infectious Diseases University of Washington Disclosures : None Learning Objective Performance Indicators Discuss the prevalence of substance use among persons in the United States Describe HCV treatment responses in persons with substance use disorders compared with those who do not have substance use disorders Summarize HCV treatment eligibility in persons who have a past or current substance use disorder List support services and management strategies for persons with substance use disorders who have chronic HCV infection Explain the concept of HCV reinfection in persons who inject drugs Background Substance use disorders are common in the United States, with 2022 data indicating that nearly 1 in 4 (24.9%) of persons 12 years of age or older used an illicit drug in the past year (Figure 1).[1] The availability of highly effective direct-acting antiviral (DAA) medications has radically changed the assessment and consideration of substance use in hepatitis C virus (HCV) treatment decisions
